LBO — BAILEY MEDICAL CENTER
IRR: 16.0% | MOIC: 2.10x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.0%
IRR
2.10x
MOIC
$74.8M
Entry EV
$110.2M
Exit EV
$38.5M
Equity Invested
Sources & Uses
S&UTotal · $74.8M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $29.0M | 38.8% | |
| Sub Debt | $7.3M | 9.7% | |
| Equity | $38.5M | 51.5% | |
| Enterprise Value | $72.6M | 97.1% | |
| Transaction Fees | $2.2M | 2.9% | |
| Total Uses | $74.8M | 100.0% |
Interpretation
INTAt 2.10x MOIC and 16.0% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $10.5M |
| Exit Ev | $110.2M |
| Net Debt At Exit | $29.3M |
| Equity At Exit | $81.0M |
| Equity Invested | $38.5M |
| Total Value Created | $42.5M |
| Value From Growth | $34.0M |
| Value From Multiple | $3.6M |
| Value From Deleveraging | $7.1M |